{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:32:58Z","timestamp":1777264378185,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81772002"],"award-info":[{"award-number":["81772002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Science Technology and Innovation Commission","award":["JCYJ20170818143334365, JCYJ20230808104859039"],"award-info":[{"award-number":["JCYJ20170818143334365, JCYJ20230808104859039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11064-026-04693-y","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:57:33Z","timestamp":1771343853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rotating Magnetic Field Therapy Induces System-Level Neuroprotection in A53T \u03b1-Synuclein Transgenic Mice Through Coordinated Suppression of Cellular Stress Pathways"],"prefix":"10.1007","volume":"51","author":[{"given":"Umer","family":"Anayyat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Naeem","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliza","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuohang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangsen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunpeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"1","key":"4693_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","volume":"11","author":"D Athauda","year":"2015","unstructured":"Athauda D, Foltynie T (2015) The ongoing pursuit of neuroprotective therapies in Parkinson disease. Nat Rev Neurol 11(1):25\u201340","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"4693_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM-Y (2002) Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein. Neuron 34(4):521\u2013533","journal-title":"Neuron"},{"issue":"2","key":"4693_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nrneurol.2016.196","volume":"13","author":"AJ Espay","year":"2017","unstructured":"Espay AJ, Brundin P, Lang AE (2017) Precision medicine for disease modification in Parkinson disease. Nat Rev Neurol 13(2):119\u2013126","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"4693_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon RA (2013) The role of autophagy in neurodegenerative disease. Nat Med 19(8):983\u2013997","journal-title":"Nat Med"},{"issue":"10","key":"4693_CR5","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41588-020-0696-0","volume":"52","author":"R Nativio","year":"2020","unstructured":"Nativio R, Lan Y, Donahue G, Sidoli S, Berson A, Srinivasan AR et al (2020) An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer\u2019s disease. Nat Genet 52(10):1024\u201335","journal-title":"Nat Genet"},{"issue":"1","key":"4693_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(08)70291-6","volume":"8","author":"AL Benabid","year":"2009","unstructured":"Benabid AL, Chabardes S, Mitrofanis J, Pollak P (2009) Deep brain stimulation of the subthalamic nucleus for the treatment of parkinson\u2019s disease. Lancet Neurol 8(1):67\u201381","journal-title":"Lancet Neurol"},{"issue":"5","key":"4693_CR7","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1212\/WNL.48.5.1398","volume":"48","author":"R Chen","year":"1997","unstructured":"Chen R, Classen J, Gerloff C, Celnik P, Wassermann E, Hallett M et al (1997) Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 48(5):1398\u2013403","journal-title":"Neurology"},{"issue":"6","key":"4693_CR8","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1007\/s11357-024-01223-y","volume":"46","author":"M Li","year":"2024","unstructured":"Li M, Yu Q, Anayyat U, Yang H, Wei Y, Wang X (2024) Rotating magnetic field improved cognitive and memory impairments in a sporadic ad model of mice by regulating microglial polarization. GeroScience 46(6):6229\u20136256","journal-title":"GeroScience"},{"issue":"6","key":"4693_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/ana.22629","volume":"71","author":"SM Goldman","year":"2012","unstructured":"Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS et al (2012) Solvent exposures and Parkinson disease risk in twins. Ann Neurol 71(6):776\u201384","journal-title":"Ann Neurol"},{"issue":"8","key":"4693_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrn3068","volume":"12","author":"J Bov\u00e9","year":"2011","unstructured":"Bov\u00e9 J, Mart\u00ednez-Vicente M, Vila M (2011) Fighting neurodegeneration with rapamycin: mechanistic insights. Nat Rev Neurosci 12(8):437\u2013452","journal-title":"Nat Rev Neurosci"},{"key":"4693_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","volume":"84","author":"M Perluigi","year":"2015","unstructured":"Perluigi M, Di Domenico F, Butterfield DA (2015) mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy. Neurobiol Dis 84:39\u201349","journal-title":"Neurobiol Dis"},{"issue":"1","key":"4693_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine B, Kroemer G (2019) Biological functions of autophagy genes: a disease perspective. Cell 176(1):11\u201342","journal-title":"Cell"},{"issue":"4\u20136","key":"4693_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mam.2011.10.006","volume":"32","author":"BM Hybertson","year":"2011","unstructured":"Hybertson BM, Gao B, Bose SK, McCord JM (2011) Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med 32(4\u20136):234\u2013246","journal-title":"Mol Aspects Med"},{"issue":"11","key":"4693_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142340","volume":"10","author":"R Siman","year":"2015","unstructured":"Siman R, Cocca R, Dong Y (2015) The mTOR inhibitor rapamycin mitigates perforant pathway neurodegeneration and synapse loss in a mouse model of early-stage Alzheimer-type tauopathy. PLoS One 10(11):e0142340","journal-title":"PLoS One"},{"issue":"37","key":"4693_CR15","doi-asserted-by":"publisher","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","volume":"30","author":"B Dehay","year":"2010","unstructured":"Dehay B, Bov\u00e9 J, Rodr\u00edguez-Muela N, Perier C, Recasens A, Boya P et al (2010) Pathogenic lysosomal depletion in parkinson\u2019s disease. J Neurosci 30(37):12535\u201312544","journal-title":"J Neurosci"},{"issue":"9","key":"4693_CR16","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nn.2372","volume":"12","author":"LS Tain","year":"2009","unstructured":"Tain LS, Mortiboys H, Tao RN, Ziviani E, Bandmann O, Whitworth AJ (2009) Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci 12(9):1129\u20131135","journal-title":"Nat Neurosci"},{"key":"4693_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.brainres.2007.01.131","volume":"1144","author":"RJ Jakel","year":"2007","unstructured":"Jakel RJ, Townsend JA, Kraft AD, Johnson JA (2007) Nrf2-mediated protection against 6-hydroxydopamine. Brain Res 1144:192\u2013201","journal-title":"Brain Res"},{"issue":"1","key":"4693_CR18","first-page":"732596","volume":"2015","author":"DR Bruns","year":"2015","unstructured":"Bruns DR, Drake JC, Biela LM, Peelor FF III, Miller BF, Hamilton KL (2015) Nrf2 signaling and the slowed aging phenotype: evidence from long-lived models. Oxidative Med Cell Longev 2015(1):732596","journal-title":"Oxidative Med Cell Longev"},{"issue":"3","key":"4693_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/ars.2008.2242","volume":"11","author":"MJ Calkins","year":"2009","unstructured":"Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, Williamson TP et al (2009) The Nrf2\/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal 11(3):497\u2013508","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"4693_CR20","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1083\/jcb.201003122","volume":"190","author":"AR Winslow","year":"2010","unstructured":"Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA et al (2010) \u03b1-Synuclein impairs macroautophagy: implications for Parkinson\u2019s disease. J Cell Biol 190(6):1023\u201337","journal-title":"J Cell Biol"},{"issue":"5","key":"4693_CR21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","volume":"93","author":"FM Menzies","year":"2017","unstructured":"Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A et al (2017) Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron 93(5):1015\u201334","journal-title":"Neuron"},{"issue":"5688","key":"4693_CR22","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant \u03b1-synuclein by chaperone-mediated autophagy. Science 305(5688):1292\u20131295","journal-title":"Science"},{"issue":"7638","key":"4693_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481\u20137","journal-title":"Nature"},{"issue":"4","key":"4693_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405","journal-title":"Lancet Neurol"},{"issue":"6301","key":"4693_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM (2016) How neuroinflammation contributes to neurodegeneration. Science 353(6301):777\u2013783","journal-title":"Science"},{"issue":"7","key":"4693_CR26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kam T-I, Panicker N, Kim S, Oh Y, Park J-S et al (2018) Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat Med 24(7):931\u20138","journal-title":"Nat Med"},{"issue":"6","key":"4693_CR27","doi-asserted-by":"publisher","first-page":"7597","DOI":"10.1007\/s12035-025-04725-8","volume":"62","author":"R Mukherjee","year":"2025","unstructured":"Mukherjee R, Rana R, Mehan S, Khan Z, Das Gupta G, Narula AS et al (2025) Investigating the interplay between the Nrf2\/Keap1\/HO-1\/SIRT-1 pathway and the p75NTR\/PI3K\/Akt\/MAPK cascade in neurological disorders: mechanistic insights and therapeutic innovations. Mol Neurobiol 62(6):7597\u20137646","journal-title":"Mol Neurobiol"},{"issue":"10","key":"4693_CR28","first-page":"1277","volume":"70","author":"JH Kang","year":"2013","unstructured":"Kang JH, Irwin DJ, Chen-Plotkin AS, Siderowf A, Caspell C, Coffey CS et al (2013) Association of cerebrospinal fluid \u03b2-amyloid 1\u201342, T-tau, P-tau181, and \u03b1-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. JAMA Neurol 70(10):1277\u20131287","journal-title":"JAMA Neurol"},{"issue":"4","key":"4693_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.proghi.2008.07.001","volume":"43","author":"RH Funk","year":"2009","unstructured":"Funk RH, Monsees T, Ozkucur N (2009) Electromagnetic effects - From cell biology to medicine. Prog Histochem Cytochem 43(4):177\u2013264","journal-title":"Prog Histochem Cytochem"},{"issue":"8","key":"4693_CR30","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/jcmm.12088","volume":"17","author":"ML Pall","year":"2013","unstructured":"Pall ML (2013) Electromagnetic fields act via activation of voltage-gated calcium channels to produce beneficial or adverse effects. J Cell Mol Med 17(8):958\u2013965","journal-title":"J Cell Mol Med"},{"key":"4693_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2013.00279","volume":"7","author":"CS Herrmann","year":"2013","unstructured":"Herrmann CS, Rach S, Neuling T, Str\u00fcber D (2013) Transcranial alternating current stimulation: a review of the underlying mechanisms and modulation of cognitive processes. Front Hum Neurosci 7:279","journal-title":"Front Hum Neurosci"},{"issue":"5321","key":"4693_CR32","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al (1997) Mutation in the alpha-synuclein gene identified in families with parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"10","key":"4693_CR33","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1111\/ejn.12166","volume":"37","author":"B Marchetti","year":"2013","unstructured":"Marchetti B, L\u2019Episcopo F, Morale MC, Tirolo C, Testa N, Caniglia S et al (2013) Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson\u2019s disease: the Wnt\/\u03b2-catenin signaling cascade as the common final pathway for neuroprotection and self-repair. Eur J Neurosci 37(10):1550\u201363","journal-title":"Eur J Neurosci"},{"issue":"5","key":"4693_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C et al (2014) Plasma exosomal \u03b1-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease. Acta Neuropathol 128(5):639\u201350","journal-title":"Acta Neuropathol"},{"issue":"1","key":"4693_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin Y, Seldin M, Lusis A (2017) Multi-omics approaches to disease. Genome Biol 18(1):83","journal-title":"Genome Biol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04693-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04693-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04693-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:36:51Z","timestamp":1777261011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04693-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4693"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04693-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"77"}}